Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0225
0.00 (0.00%)
Sep 26, 2024, 11:00 AM EDT
Oncotelic Therapeutics Revenue
Oncotelic Therapeutics had revenue of $70.00K in the twelve months ending June 30, 2024. In the year 2023, Oncotelic Therapeutics had annual revenue of $70.00K.
Revenue
70.00K
Revenue Growth
n/a
P/S Ratio
127.14
Revenue / Employee
3.18K
Employees
22
Market Cap
9.04M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Medexus Pharmaceuticals Inc. | 108.78M |